Galera Therapeutics is aiming to transform radiotherapy for patients with cancer by developing novel therapies to reduce radiotherapy-induced toxicities and improve the anti-cancer efficacy of radiation.

Prioritizing Patients Receiving Radiotherapy Through First-in-class Science

We are pioneering a new scientific approach with the goal of improving both treatment and outcomes for patients with cancer receiving radiotherapy. We believe that our unique science leverages superoxide dismutase mimetics to reduce radiotherapy-induced toxicities and to increase the anti-cancer efficacy of radiation therapy.

Science Behind Dismutase Mimetics

Commitment to Patients